Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Advanced therapies
  • Virology
  • Diagnostics
  • Biotherapeutics
  • Bacteriology
  • Analytical sciences
  • A to Z listing
  • Publications
  • Home  /  
  • Science and research  /  
  • Biotherapeutics  /  
  • Nanobodies  /  
  • Influenza A - Group 2: H3 and H7

Influenza A – Group 2: H3 and H7

Single-domain antibodies (VHH nanobodies) generated from immunised alpacas. The panel comprises H3- and H7-specific and cross-reactive H3/H7 VHHs, spanning reactivities across multiple strains and years.

Some of these nanobodies are featured in the following publication.

Gaiotto T, Ramage W, Ball C, Risley P, Carnell GW, Temperton N, Engelhardt OG, Hufton SE. Nanobodies mapped to cross-reactive and divergent epitopes on A(H7N9) influenza hemagglutinin using yeast display. Sci Rep. 2021 Feb 4;11(1):3126. doi: 10.1038/s41598-021-82356-4.

For enquiries visit: Non-Exclusive Licensing Enquiry Form for Nanobodies

 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap